Cargando…

Fabrizio VA, Boelens JJ, Mauguen A, et al. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022;6(7):1961-1968.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333729/ https://www.ncbi.nlm.nih.gov/pubmed/37368453 http://dx.doi.org/10.1182/bloodadvances.2023010269

Ejemplares similares

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy
por: Fabrizio, Vanessa A., et al.
Publicado: (2022)

Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
por: Sidana, Surbhi, et al.
Publicado: (2023)

Fabrizio Lupo
por: Còccioli, Carlo
Publicado: (1971)

Gill S, Vides V, Frey NV, et al. Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia. Blood Adv. 2022;6(21):5774-5785.
Publicado: (2023)

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
por: Ma, Yunju, et al.
Publicado: (2023)

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
por: Suryadevara, Carter M., et al.
Publicado: (2018)

First person – James Fabrizio
Publicado: (2020)

Future Leader to Watch – Fabrizio Alberti
Publicado: (2020)

Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity
por: De Matteis, Serena, et al.
Publicado: (2023)

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment
por: Marquard, Franziska, et al.
Publicado: (2023)

Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma
por: Acosta-Medina, Aldo A., et al.
Publicado: (2023)

Lissitchkov T, Willemze A, Katragadda S, et al. Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study. Blood Adv. 2022;6(4):1089-1094.
Publicado: (2022)

Tam CS, Dimopoulos M, Garcia-Sanz R, et al. Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood Adv. 2022;6(4):1296-1308.
Publicado: (2022)

J.J. Rousseau /
por: Faguet, Emile, 1847-1916
Publicado: (1945)

Eshel A, Sharon I, Nagler A, et al. Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis. Blood Adv. 2022;6(2):568-573.
Publicado: (2022)

Shouval R, Fein JA, Cho C, et al. The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT. Blood Adv. 2022;6(5):1525-1535.
Publicado: (2022)

Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229.
Publicado: (2022)

van Rhee F, Rosenthal A, Kanhai K, et al. Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease. Blood Adv. 2022;6(16):4773-4781.
Publicado: (2023)

Modeling the dynamics of the novel coronavirus using Caputo-Fabrizio derivative
por: Alzahrani, Ebraheem, et al.
Publicado: (2021)

Study on the mathematical modelling of COVID-19 with Caputo-Fabrizio operator
por: Rahman, Mati ur, et al.
Publicado: (2021)

Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. Blood Adv. 2022;6(21):5716-5731.
Publicado: (2023)

Electroweak production of $Z$jj and $W^{\pm}W^{\pm}$jj states at the LHC
por: Pagan Griso, S.
Publicado: (2014)

Karihtala K, Leivonen S-K, Karjalainen-Lindsberg M-L, et al. Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients. Blood Adv. 2022;6(6):1919-1931.
Publicado: (2023)

Lisi V, Blanchard È, Vladovsky M, et al. Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia. Blood Adv. 2022;6(17):5160-5164.
Publicado: (2023)

Nawas MT, Sanchez-Escamilla M, Devlin SM, et al. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6(22):5898-5907.
Publicado: (2023)

Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia
por: Wang, Jia, et al.
Publicado: (2020)

Kudo K, Kubota Y, Toki T, et al. Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report. Blood Adv. 2022;6(10):3162-3166.
Publicado: (2022)

Smith CC, Levis MJ, Perl AE, et al. Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib. Blood Adv. 2022;6(7):2144-2155.
Publicado: (2022)

Joh. Christoph Gottsched und die Schweizer J.J. Bodmer und J.J. Breitinger
por: Gottsched, Johann Christoph, 1700-1766
Publicado: (1884)

J.J. Thompson and the discovery of the electron
por: Davis, E A, et al.
Publicado: (2002)

Professor Hein JJ Wellens, In memoriam
por: Nabar, Ashish, et al.
Publicado: (2020)

Using caputo-fabrizio derivative for the transmission of mathematical model epidemic Corona Virus
por: Tahir, M., et al.
Publicado: (2020)

A fractional model of cancer-immune system with Caputo and Caputo–Fabrizio derivatives
por: Uçar, Esmehan, et al.
Publicado: (2021)

A FRACTIONAL ORDER HIV/AIDS MODEL USING CAPUTO-FABRIZIO OPERATOR
por: Unaegbu, Ebenezar Nkemjika, et al.
Publicado: (2021)

Analysis and dynamical transmission of Covid-19 model by using Caputo-Fabrizio derivative
por: Farman, Muhammad, et al.
Publicado: (2023)

J.J. Rousseau : la profesión de fe del filósofo /
por: Rousseau, Jean-Jacques, 1712-1778
Publicado: (1984)

Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022;6(4):1243-1254.
Publicado: (2023)

Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993.
Publicado: (2023)

Erratum to “Cardiac Damage Staging Classification in Asymptomatic Moderate or Severe Primary Mitral Regurgitation”: [Structural Heart 2022;6(1):100004]
Publicado: (2023)

In Memoriam: Professor Paolo Muiesan (1961–2022)
por: Fondevila, Constantino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ki17m9j15f86u2a922e7kh5p5h